RenX Enterprises Corp. 8-K

What Happened

• RenX Enterprises Corp. (RENX) announced it received a notice from Nasdaq on January 26, 2026, that its common stock failed to maintain the $1.00 minimum closing bid required by Nasdaq Listing Rule 5550(a)(2) for the 30 consecutive business days from December 5, 2025 through January 20, 2026.
• The notice does not have an immediate effect on the listing or trading of RENX shares, which will continue to trade on The Nasdaq Capital Market under the ticker “RENX.”

Key Details

• Notice received: January 26, 2026; deficiency period: Dec 5, 2025–Jan 20, 2026 (30 consecutive business days).
• Compliance period: 180 calendar days, ending July 27, 2026, to regain compliance.
• Cure condition: closing bid of at least $1.00 for a minimum of 10 consecutive business days (Nasdaq may require more than 10 days).
• Company response: intends to monitor the bid price and may consider actions such as a reverse stock split; could seek a second compliance period if it meets other initial listing standards and notifies Nasdaq in writing.

Why It Matters

• For investors, this is a formal warning that RENX risks delisting from Nasdaq if it does not meet the $1.00 minimum bid requirement by July 27, 2026.
• There is no immediate trading suspension or delisting—shares remain tradable—but potential remedies (e.g., a reverse stock split) could affect share count and per-share price.
• Monitor future company filings for updates on compliance progress or any corporate actions to cure the deficiency.